Vertical Focus Tellic serves the Pharma and Biotech sector by automating extraction of genetic evidence and building a knowledge graph for target selection, clinical trial design, and BD. This creates a clear opportunity to upsell to larger pharma players seeking scalable data science workflows and faster decision making.

Low Headcount Scalability With a small team of 2-10 employees, Tellic may benefit from strategic partnerships and managed services to scale delivery for larger clients, making them an attractive contractor for pilot projects and co-development engagements.

Tech Stack Levers Tellic already leverages cloud-based tooling and data orchestration (Airflow, Google Cloud) plus visualization and frontend technologies. This suggests opportunities to offer integration, data pipeline modernization, or BI enhancements to existing customers using familiar platforms.

Evidence to Insight The core product converts biomedical text into actionable knowledge graphs for target discovery and protocol design. Sales can frame value around accelerated research timelines, reduced manual curation, and improved hypothesis testing for drug development pipelines.

Growth Readiness Revenue is in the early-to-mid range and comparable to niche data science vendors. There is potential for expansion via reference-able pilots, case studies with biotech sponsors, and tiered service offerings aimed at mid-sized pharma and CROs seeking specialized AI-enabled evidence extraction.